{
  "disease_name": "Colorectal cancer",
  "synonyms": [
    "Bowel cancer",
    "Colon cancer",
    "Rectal cancer",
    "CRC"
  ],
  "summary": "A malignant neoplasm arising in the colon or rectum, typically progressing from adenomatous polyps and driven by genetic and epigenetic alterations (e.g., APC/Wnt pathway, KRAS, TP53) with risk modulated by lifestyle, inherited syndromes, chronic inflammation, and gut microbiome.",
  "causes": [
    "APC mutation and Wnt pathway dysregulation",
    "TP53 inactivation",
    "KRAS activation",
    "BRAF mutation",
    "MMR deficiency (microsatellite instability)",
    "Epigenetic silencing of tumor suppressors",
    "Adenoma–carcinoma sequence",
    "Microbiome dysbiosis (e.g., Fusobacterium nucleatum)",
    "Colibactin-producing Escherichia coli"
  ],
  "risk_factors": [
    "Older age",
    "Family history of colorectal cancer",
    "Adenomatous polyps (adenomas)",
    "Inflammatory bowel disease (ulcerative colitis, Crohn disease)",
    "Lynch syndrome (HNPCC)",
    "Familial adenomatous polyposis (FAP)",
    "Diet high in red or processed meat",
    "Alcohol intake",
    "Smoking",
    "Obesity",
    "Physical inactivity",
    "Black race (higher incidence and mortality)"
  ],
  "symptoms": [
    "Blood in stool",
    "Change in bowel habits",
    "Constipation",
    "Diarrhea",
    "Narrow stools",
    "Sensation of incomplete evacuation",
    "Abdominal pain or cramping",
    "Bloating or gas",
    "Unintentional weight loss",
    "Fatigue"
  ],
  "diagnosis": [
    "Colonoscopy with polypectomy/biopsy",
    "Flexible sigmoidoscopy",
    "Stool tests (FOBT, FIT, FIT-DNA)",
    "Digital rectal exam",
    "CT imaging (staging)",
    "MRI (rectal staging and response assessment)",
    "PET in selected cases",
    "Blood and tissue tests"
  ],
  "treatments": [
    "Surgery (partial colectomy/proctectomy; endoscopic resection when feasible)",
    "Chemotherapy (e.g., FOLFOX, FOLFIRI, CAPOX; fluorouracil, capecitabine, oxaliplatin, irinotecan)",
    "Radiation therapy (particularly for rectal cancer)",
    "Targeted therapy (EGFR inhibitors, anti-VEGF such as bevacizumab)",
    "Immunotherapy (PD-1 inhibitors for MSI-H/dMMR tumors)",
    "Radiofrequency ablation",
    "Cryoablation",
    "Active surveillance (selected early rectal cancer after complete clinical response)"
  ],
  "related_genes": [
    "APC",
    "CTNNB1",
    "AXIN1",
    "AXIN2",
    "TCF7L2",
    "TP53",
    "KRAS",
    "BRAF",
    "PIK3CA",
    "PTEN",
    "SMAD4",
    "TGFBR2",
    "MACC1",
    "POLE",
    "POLD1",
    "MSH3",
    "MSH6",
    "ACVR2A",
    "ATM",
    "ARID1A"
  ],
  "subtypes": [
    {
      "name": "Colon adenocarcinoma",
      "typical_patients": "Adults; incidence increases with age",
      "five_year_survival": "≈65% overall (US, 2014)",
      "common_treatments": [
        "Surgery",
        "Chemotherapy",
        "Targeted therapy"
      ]
    },
    {
      "name": "Rectal adenocarcinoma",
      "typical_patients": "Adults; incidence increases with age",
      "five_year_survival": "≈67–90% depending on stage and treatment",
      "common_treatments": [
        "Chemoradiotherapy",
        "Surgery",
        "Chemotherapy",
        "Active surveillance (selected)"
      ]
    },
    {
      "name": "MSI-H/dMMR colorectal cancer",
      "typical_patients": "Subset with mismatch repair deficiency (sporadic or Lynch syndrome)",
      "five_year_survival": "",
      "common_treatments": [
        "Immunotherapy (PD-1 inhibitors)",
        "Surgery",
        "Chemotherapy (context-dependent)"
      ]
    }
  ],
  "epidemiology": {
    "global_cases_2015": "",
    "global_deaths_2015": "",
    "most_common_in": "Developed countries",
    "five_year_survival_rate": "≈60–65% (varies by stage and region)"
  },
  "relationships": [
    {
      "source": "Colorectal cancer",
      "relation": "has_symptom",
      "target": "Blood in stool"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_symptom",
      "target": "Change in bowel habits"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_symptom",
      "target": "Abdominal pain or cramping"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_symptom",
      "target": "Unintentional weight loss"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_symptom",
      "target": "Fatigue"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Older age"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Adenomatous polyps"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Inflammatory bowel disease"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Diet high in red or processed meat"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Alcohol intake"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Smoking"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Obesity"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Physical inactivity"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_risk_factor",
      "target": "Family history of colorectal cancer"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_precursor",
      "target": "Adenomatous polyp"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_cause",
      "target": "APC mutation and Wnt pathway dysregulation"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_cause",
      "target": "TP53 inactivation"
    },
    {
      "source": "Colorectal cancer",
      "relation": "has_cause",
      "target": "MMR deficiency"
    },
    {
      "source": "Colorectal cancer",
      "relation": "associated_gene",
      "target": "APC"
    },
    {
      "source": "Colorectal cancer",
      "relation": "associated_gene",
      "target": "KRAS"
    },
    {
      "source": "Colorectal cancer",
      "relation": "associated_gene",
      "target": "BRAF"
    },
    {
      "source": "Colorectal cancer",
      "relation": "associated_gene",
      "target": "TP53"
    },
    {
      "source": "Colorectal cancer",
      "relation": "associated_gene",
      "target": "MSH6"
    },
    {
      "source": "Colorectal cancer",
      "relation": "treated_with",
      "target": "Surgery"
    },
    {
      "source": "Colorectal cancer",
      "relation": "treated_with",
      "target": "Chemotherapy"
    },
    {
      "source": "Colorectal cancer",
      "relation": "treated_with",
      "target": "Radiation therapy"
    },
    {
      "source": "Colorectal cancer",
      "relation": "treated_with",
      "target": "Targeted therapy"
    },
    {
      "source": "Colorectal cancer",
      "relation": "treated_with",
      "target": "Immunotherapy"
    },
    {
      "source": "Colon adenocarcinoma",
      "relation": "subtype_of",
      "target": "Colorectal cancer"
    },
    {
      "source": "Rectal adenocarcinoma",
      "relation": "subtype_of",
      "target": "Colorectal cancer"
    },
    {
      "source": "MSI-H/dMMR colorectal cancer",
      "relation": "subtype_of",
      "target": "Colorectal cancer"
    }
  ]
}